Merck spends $11.5B for Acceleron, possible blockbuster drug
Merck will spend about $11.5 billion to buy Acceleron Pharma and its potential treatment for high blood pressure in vessels that connect the lungs and heart.
Sep 30, 2021
0
1
Merck will spend about $11.5 billion to buy Acceleron Pharma and its potential treatment for high blood pressure in vessels that connect the lungs and heart.
Sep 30, 2021
0
1
Health care experts urge increased awareness of obstructive sleep apnea among people with cardiovascular disease or risk factors such as high blood pressure, according to a new scientific statement from the American Heart ...
Jun 21, 2021
0
4
Anew physiological measurement of heart function developed at UVA Health could improve survival for heart-failure patients by identifying high-risk patients who require tailored treatments, a study has found.
Jun 8, 2021
0
0
Exercise appears to reduce the long-term risk of bronchiectasis, a potentially serious disease of the airways, according to a study published in the journal Radiology.
Apr 27, 2021
0
2
Screening for a sometimes fatal condition among patients with a rare autoimmune disease could soon—thanks to a computer algorithm—become even more accurate.
Apr 21, 2021
0
10
For patients receiving background therapy for pulmonary arterial hypertension, treatment with sotatercept results in a reduction in pulmonary vascular resistance, according to a study published in the April 1 issue of the ...
Apr 1, 2021
0
5
Extremely low birth weight (ELBW) infants with moderate to large patent ductus arteriosus (PDA) may benefit from transcatheter PDA closure (TCPC) in the first four weeks of life, according to research published by Le Bonheur ...
Feb 26, 2021
0
3
Heart and respiratory symptoms caused by cold weather predict higher morbidity and mortality. The researchers were surprised to find that symptoms related to cold weather increased morbidity and mortality in healthy individuals. ...
Nov 18, 2020
0
1
(HealthDay)—Influenza vaccination may have a protective effect for COVID-19-positive patients, according to a brief report recently published in the Journal of the American Board of Family Medicine.
Nov 3, 2020
0
218
Pulmonary arterial hypertension (PAH) is a rare—albeit deadly—disease that affects the arteries of the lung. In PAH, abnormal growth of cells of the vascular media—or the elastic wall—of the pulmonary arteries, called ...
Aug 7, 2020
0
4